Dr Bernard Surial at CROI 2023. Photo by Andy Carstens.Starting treatment with an integrase inhibitor did not lead to an increased risk of heart attack, stroke or heart surgery in people with HIV in Switzerland, Dr Bernard Surial from the Swiss HIV Cohort study reported at the 30th Conference on Retroviruses and Opportunistic Infections (CROI 2023) in Seattle.
The question of whether integrase inhibitors affect cardiovascular risk has been uncertain. As with any new type of medication, large-scale study of their effects on heart disease takes time. Although integrase inhibitors are less likely to cause increases in cholesterol, people with HIV taking integrase inhibitors tend to gain more weight after starting treatment than others. Substantial weight gain might raise the risk of cardiovascular disease.
Read the full story at Aidsmap.
Source : Aidsmap
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.